1. Home
  2. AVX vs CNSY Comparison

AVX vs CNSY Comparison

Compare AVX & CNSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avax One Technology Ltd.

AVX

Avax One Technology Ltd.

HOLD

Current Price

$4.22

Market Cap

30.8M

Sector

Industrials

ML Signal

HOLD

Logo Cerenome Inc. Common Stock

CNSY

Cerenome Inc. Common Stock

N/A

Current Price

$1.66

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVX
CNSY
Founded
2017
1996
Country
United States
United States
Employees
7
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
20.6M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
AVX
CNSY
Price
$4.22
$1.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $27.75
AVG Volume (30 Days)
★ 329.4K
161.9K
Earning Date
11-13-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.55
87.61
EPS
N/A
★ N/A
Revenue
$2,340,811.00
★ $5,213,000.00
Revenue This Year
$18,042.77
N/A
Revenue Next Year
$12.21
$414.61
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 3348.10
N/A
52 Week Low
$0.35
$1.49
52 Week High
$7.38
$4.03

Technical Indicators

Market Signals
Indicator
AVX
CNSY
Relative Strength Index (RSI) 43.34 38.01
Support Level $3.02 $1.54
Resistance Level $6.25 $1.96
Average True Range (ATR) 0.69 0.17
MACD -0.20 0.04
Stochastic Oscillator 7.05 26.19

Price Performance

Historical Comparison
AVX
CNSY

About AVX Avax One Technology Ltd.

AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.

About CNSY Cerenome Inc. Common Stock

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Share on Social Networks: